Literature DB >> 28405821

[Stem cell-based approaches to diseases of the ocular surface].

U Schlötzer-Schrehardt1, F E Kruse2.   

Abstract

Mesh：

Year:  2017        PMID： 28405821     DOI： 10.1007/s00347-017-0476-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  6 in total

1.  Simple Limbal Epithelial Transplantation: Long-Term Clinical Outcomes in 125 Cases of Unilateral Chronic Ocular Surface Burns.

Authors:  Sayan Basu; Shraddha P Sureka; Swapna S Shanbhag; Abhinav R Kethiri; Vivek Singh; Virender S Sangwan
Journal:  Ophthalmology       Date:  2016-02-17       Impact factor: 12.079

Review 2.  Management of Limbal Stem Cell Deficiency: A Historical Perspective, Past, Present, and Future.

Authors:  Edward J Holland
Journal:  Cornea       Date:  2015-10       Impact factor: 2.651

Review 3.  [Cell-based therapies - an innovative therapeutic option in ophthalmology: Treating corneal diseases with stem cells].

Authors:  Ann-Christin Bakker; Barbara Langer
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2015-11       Impact factor: 1.513

4.  Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium.

Authors:  Ryuhei Hayashi; Yuki Ishikawa; Miyuki Ito; Tomofumi Kageyama; Kuniko Takashiba; Tsuyoshi Fujioka; Motokazu Tsujikawa; Hiroyuki Miyoshi; Masayuki Yamato; Yukio Nakamura; Kohji Nishida
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

Review 5.  [Classification of ocular surface disease. Part 1].

Authors:  F E Kruse; C Cursiefen; B Seitz; H E Völcker; G O H Naumann; L Holbach
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.174

Review 6.  From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU.

Authors:  Graziella Pellegrini; Alessandro Lambiase; Claudio Macaluso; Augusto Pocobelli; Sophie Deng; Gian Maria Cavallini; Roza Esteki; Paolo Rama
Journal:  Regen Med       Date:  2016-04-19       Impact factor: 3.806
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.